Endobronchial valves for persistent air leak all-cause mortality and financial impact: US trend from 2012–2016
Journal of Community Hospital Internal Medicine Perspectives · 03.09.2019 · 9 (5) · 397-402
DOI: 10.1080/20009666.2019.1675229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Community Hospital Internal Medicine Perspectives, online erschienen am 01.11.2019. Verfasst von Osama Mukhtar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Division, Interfaith Medical Center, Brooklyn, NY, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Endobronchial valves (EBV) are considered an innovation in the management of the persistent air leak (PAL). They offer a minimally invasive alternative to the traditional approach of pleurodesis and surgical intervention. We examined trends in mortality, length of stay (LOS), and resources utilization in patients who underwent EBV placement for PAL in the US.
Methods
We utilized discharge data from the Nationwide Inpatient Sample (NIS) for five years (2012-2016). We included adults diagnosed with a pneumothorax who underwent EBV insertion at ≥ 3 days from the day of chest tube placement; or following invasive thoracic procedure. We analyzed all-cause mortality, LOS, and resources utilization in the study population.
Results
A total of 1,885 cases met our inclusion criteria. Patients were mostly middle-aged, males, whites, and had significant comorbidities. The average LOS was 21.8 ± 20.5 days, the mean time for chest tube placement was 3.8 ± 5.9 days, and the mean time for EBV insertion was 10.5 ± 10.3 days. Pleurodesis was performed before and after EBV placement and in 9% and 6%, respectively.
Conclusions
Our study showed that the all-cause mortality rate fluctuated throughout the years at around 10%. Despite EBV being a minimally invasive alternative, its use has not trended up significantly during the study period. EBVs are also being used off-label in the US for spontaneous pneumothorax. This study shall provide more data to the scarce literature about EBV for PAL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonary Division, Interfaith Medical Center, Brooklyn, NY, USA.
- Department of Medicine, Interfaith Medical Center, Brooklyn, NY, USA.
- Department of Cardiothoracic Surgery, Weill-Cornell Medicine, New York, NY, USA.
ORCID-Profile: Osama Mukhtar, Mazin Khalid, Binav Shrestha, Oday Alhafdh, Manal Bakhiet
Zitieren
APA
Mukhtar, O., Khalid, M., Shrestha, B., Alhafdh, O., Pata, R., Bakhiet, M., Quist, J., Enriquez, D., Shostak, E., & Schmidt, F. (2019). Endobronchial valves for persistent air leak all-cause mortality and financial impact: US trend from 2012–2016. Journal of Community Hospital Internal Medicine Perspectives, 9(5), 397-402. https://doi.org/10.1080/20009666.2019.1675229
Vancouver
Mukhtar O, Khalid M, Shrestha B, Alhafdh O, Pata R, Bakhiet M, et al. Endobronchial valves for persistent air leak all-cause mortality and financial impact: US trend from 2012–2016. Journal of Community Hospital Internal Medicine Perspectives. 2019;9(5):397-402. doi:10.1080/20009666.2019.1675229
BibTeX
@article{Mukhtar2019,
author = {Mukhtar, Osama and Khalid, Mazin and Shrestha, Binav and Alhafdh, Oday and Pata, Ramakanth and Bakhiet, Manal and Quist, Joseph and Enriquez, Danilo and Shostak, Eugene and Schmidt, Frances},
title = {Endobronchial valves for persistent air leak all-cause mortality and financial impact: US trend from 2012–2016},
journal = {Journal of Community Hospital Internal Medicine Perspectives},
year = {2019},
volume = {9},
number = {5},
pages = {397--402},
doi = {10.1080/20009666.2019.1675229}
}
EUVIMED